Research Advance of Stem Cell Transplantation in Cardiovascular Diseases

Morbidity of myocardial infarction is increasing.Owing to the lack of replacement of necrotic cardiac myocytes,the therapeutic methods today are not sufficient to prevent left ventricular remodeling.However,the current insights into stem cell have opened up new perspectives for the infracted heart.Varied stem cells,including embryonic or foetal stem cells,myoblasts,and bone marrow stem cells,have been used for(cellular cardiomyoplasty.The review discusses recent animal experimental data and the clinical potential of varied stem cells.